{"doi":"10.3816/clm.2001.n.025","title":"Durable Remission in Recurrent T-Cell—Rich B-Cell Lymphoma with the Anti-CD20 Antibody Rituximab","abstract":null,"journal":"Clinical Lymphoma","year":2001,"id":17372,"datarank":0.47226760332452766,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.20350368294031942,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.20350368294031942,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":2,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":124549,"name":"Thomas S. Stanton","orcid":null,"position":1,"is_corresponding":false},{"id":35693,"name":"Roger A. Warnke","orcid":null,"position":2,"is_corresponding":false},{"id":124552,"name":"Sandra J. Horning","orcid":null,"position":3,"is_corresponding":false},{"id":124547,"name":"Yasodha Natkunam","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":1.791759469228055,"endowment":1.791759469228055,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"11779297","pmcid":null,"openalex_id":"https://openalex.org/W2019502863","authors":[],"funders":[],"total_grants":0,"fwci":0.8011,"citation_percentile":0.70889661,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S152696551170152X?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S152696551170152X?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.3816/clm.2001.n.025","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/11779297","host_type":"repository"}],"fields_of_study":["Lymphoma Diagnosis and Treatment","CNS Lymphoma Diagnosis and Treatment","Chronic Lymphocytic Leukemia Research","Medicine","Adult","Antibodies, Monoclonal","Antibodies, Monoclonal, Murine-Derived","Antineoplastic Agents","Humans","Immunophenotyping","Liver","Lymph Nodes","Lymphoma, B-Cell","Male","Neoplasm Recurrence, Local","Remission Induction","Rituximab","Spleen","T-Lymphocytes","Tomography, X-Ray Computed"],"mesh_terms":["Rituximab","Adult","Antibodies, Monoclonal","Antineoplastic Agents","Humans","Liver","Lymph Nodes","Male","Neoplasm Recurrence, Local","Remission Induction","Spleen","T-Lymphocytes","Tomography, X-Ray Computed","Immunophenotyping","Lymphoma, B-Cell","Antibodies, Monoclonal, Murine-Derived"],"keywords":["Rituximab","CD20","Lymphoma","Medicine","B cell","Antibody","Immunology","Disease","Pathology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-02T18:36:04.428575Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}